BIOMEDICAL STRATEGIES, LLC
NEW YORK, NY

Who We Are We are senior-level professionals with the expertise required to serve our customers’ needs fully and efficiently. Our clients range from the largest pharmaceutical and medical device companies, through medium sized companies, to start-ups, as well as State and Federal government entities. Dr. Cahn has over 30 years experience in scientific research, invention, technology and product development, clinical studies, regulatory negotiations, reimbursement and marketing. Current chairman of the ASTM comittee that deals standards for tissue engineered medical products (F04.41), Dr. Cahn has served on government peer review committees, university industrial advisory boards, and medical product standardization organizations. Ms. Galati has over 18 years experience in business development, market research, competitive analysis, product development, product launches, reimbursement, and government relations. She has worked successfully at the local and national levels with senior policy personnel at privation government third party payer organizations, including the Centers for Medicare and Medicaid Services, to ensure appropriate payment for medical devices and pharmaceuticals. Dr. Arvesen has over 30 years of quantitative marketing and bio-statistics experience. Dr. Arvesen directed market research and planning and clinical statistics at Pfizer and was a founder and the president of Amixis Inc., a successful marketing and biostatistics consulting firm. He is an authority and leader in applying advanced statistical methods to competitive intelligence for maximizing the impact of marketing and sales force resources, as well an expert in clinical statistics. Provide strategies and solutions that help our clients maximize the profitability of their medical products. We provide strategies and solutions for the entire medical product life cycle: • Reimbursement Coverage, Payment & Coding, 3rd Party Insurers • Medical Economics, Outcomes, Statistics • Clinical Studies Reimbursement is critical to market success for products that are administered in hospitals or clinics. BMS advises planning for reimbursement at every stage of product development. Reimbursement issues, such as whether new or existing medical codes are appropriate, affect regulatory choices in product claims and labeling and (for devices) whether to prepare 510(k) vs.PMA applications. We have over 30 years of experience and the expertise your business needs to succeed in the medical marketplace. We have successfully created and executed reimbursement strategies for many medical manufacturers and investment organizations, ranging from start-ups to large enterprises. Our decades of industry experience, coupled with our innovative mindset, will win government approval and secure maximum profits for your business. We provide strategies and solutions for the entire medical product life cycle: Achieving success in marketing medical products demands sophisticated marketing strategies and careful attention to reimbursement issues. We are expert consultants in all components of successful medical reimbursement programs: Economic and statistical analysis, Marketing research, Governmental relations, Securing critical new codes from Medicare and 3rd-party insurers, Winning favorable coverage decisions, and Securing add-on payments for innovative technologies. We will help you navigate complicated government and corporate policies and will make a positive economic difference in your business. Provide strategies and solutions that help our clients maximize the profitability of their medical products. We provide strategies and solutions for the entire medical product life cycle: • Reimbursement Coverage, Payment & Coding, 3rd Party Insurers • Medical Economics, Outcomes, Statistics • Clinical Studies